DECN:Buy and Hold.This is David that just Won it's Freedom against J&J Goliath...
Decision Diagnostics has won all the important parts of their case recently. Free to sell their product, they are set on track for a profitable future and have removed the proverbial sword of Damocles from over their head.
Johnson and Johnson makes 2.6 billion annually in diabetes diagnostics sales, mainly from the disposable strips for their devices.
It's not unlikely that J&J will acquire Decision Diagnostics for a fraction of their behemoth revenues in DDS, eliminating a dangerous competitor and guaranteeing future control of the market.
As an investor this would be the greatest opportunity to capitalize on this stock, and as such one that I am eager to see.
Expect a steady rise in pps and value pretty soon as sales revenue begins accumulating and begin to post profits within the coming quarters.